NUWELLIS, INC.

NUWE ·Healthcare, Medical Devices, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2017 FY2016 FY2015 FY2014 FY2013 FY2012
Revenue $3.6M $1.3M $59.0K $295.0K $59.0K $0
Cost of Revenue $2.8M $713.0K
Gross Profit $790.0K $576.0K
Gross Margin 22.2% 44.7%
Operating Expenses
Research & Development $1.5M $8.1M $17.7M $16.9M $13.5M $8.0M
SG&A Expense $10.2M $8.1M $8.3M $9.2M $9.4M $6.9M
Operating Income $-14.8M $-15.7M $-26.0M $-25.8M $-22.9M $-14.9M
Operating Margin -416.9% -1,215.1% -43,996.6% -8,741.4% -38,764.4%
Interest Expense $504.0K $743.0K
Pretax Income $-13.4M $-15.8M $-26.7M $-25.8M $-23.0M $-14.8M
Income Tax Expense $6.0K $-54.0K $-124.0K $-249.0K $-1.2M $-771.0K
Net Income $-13.4M $-15.8M $-26.6M $-25.6M $-21.8M $-14.1M
Net Margin -376.6% -1,225.1% -45,055.9% -8,673.6% -36,878.0%
EPS (Basic) $-7.95 $-8.12 $-0.67 $-0.02 $-0.03 $-0.03
EPS (Diluted) $-7.95 $-8.12 $-0.67 $-0.02 $-0.03 $-0.03
Shares Outstanding (Basic) 17.9M 2.6M 40.4M 1.12B 1.11B 612.7M
Shares Outstanding (Diluted) 17.9M 2.6M 40.4M 1.12B 1.11B 612.7M
Dividends Per Share
← Newer Page 2 of 2 Older →